BlackRock Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

BlackRock Advisors’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8K	Sell	127 -38	-23%	-$2.37K	﹤0.01%	3596
2016 Q3	$11K	Buy	165 +38	+30%	+$2.45K	﹤0.01%	3567
2016 Q2	$9K	Sell	127 -150	-54%	-$15K	﹤0.01%	3598
2016 Q1	$31K	Hold	277	–	–	﹤0.01%	3316
2015 Q4	$42K	Sell	277 -131	-32%	-$19.6K	﹤0.01%	3267
2015 Q3	$44K	Hold	408	–	–	﹤0.01%	3343
2015 Q2	$58K	Buy	+408	New	+$94.6K	﹤0.01%	3312

Other funds holding CALA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Advisors's CALA Position: Q4 2016 in Review

BlackRock Advisors reduced its Calithera Biosciences, Inc (CALA) stake by 23% in Q4 2016, selling an estimated $2.37K and leaving 127 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #3596.

BlackRock Advisors first reported a position in CALA in Q2 2015 and has held it in 7 quarters since. The position peaked at $58K in Q2 2015. 33 funds tracked by Wall St. Rank hold CALA as of Q4 2016.

BlackRock Advisors held 127 shares of Calithera Biosciences, Inc worth $8K as of Q4 2016.
BlackRock Advisors sold 38 Calithera Biosciences, Inc shares in Q4 2016, an estimated $2.37K.
Calithera Biosciences, Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3596 holding.
BlackRock Advisors first reported a position in Calithera Biosciences, Inc in Q2 2015 and has held it in 7 quarters since.
BlackRock Advisors's Calithera Biosciences, Inc position peaked at $58K in Q2 2015.
33 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.